It’s Getting Harder To Track New Covid Variants
The World Health Organization, CNBC reports, is finding it hard to identify emerging covid variants, which could endanger the fight against the virus. Meanwhile, AP reports 4.4 million Americans have received the updated booster shots designed to target omicron covid.
CNBC:
WHO Warns Ability To Identify New Covid Variants Is Diminishing
The World Health Organization on Thursday warned that it is struggling to identify and track new Covid variants as governments roll back testing and surveillance, threatening the progress made in the fight against the virus. (Kimball, 9/22)
In updates on the covid vaccine rollout —
AP:
4.4M Americans Roll Up Sleeves For Omicron-Targeted Boosters
U.S. health officials say 4.4 million Americans have rolled up their sleeves for the updated COVID-19 booster shot. The Centers for Disease Control and Prevention posted the count Thursday as public health experts bemoaned President Joe Biden’s recent remark that “the pandemic is over.” The White House said more than 5 million people received the new boosters by its own estimate that accounts for reporting lags in states. (Johnson, 9/23)
AP:
Canada To Drop Vaccine Mandate At Border Sept. 30
Prime Minister Justin Trudeau has signed off on Canada dropping the vaccine requirement for people entering the country at the end of September, an official familiar with the matter told The Associated Press on Thursday. Canada, like the United States, requires foreign nationals to be vaccinated when entering the country. No change in the mandate is expected in the U.S. in the near term. (Gillies, 9/22)
KHN:
KHN’s ‘What The Health?’: Biden Declares The Pandemic ‘Over’
President Joe Biden’s declaration in a national interview that the covid-19 pandemic is “over” has complicated his own administration’s efforts to get Congress to provide more funding for treatments and vaccines, and to get the public to go get yet another booster. Meanwhile, concerns about a return of medical inflation for the first time in a decade is helping boost insurance premiums, and private companies are scrambling to claim their piece of the health care spending pie. (9/22)
In news about Paxlovid and other covid treatments —
Axios:
New Analysis Supports Paxlovid Use
Here's one more data point to consider in the back-and-forth about Pfizer's antiviral pill Paxlovid: A new analysis found it can meaningfully reduce COVID hospitalizations and deaths, even in those younger than 65. (Reed, 9/22)
Axios:
Pfizer To Supply 6 Million Paxlovid Treatments To Global Fund
Pfizer will supply up to six million Paxlovid treatments to the Global Fund in an effort toward equitable access to COVID-19 oral treatments, the company announced Thursday. (Habeshian, 9/22)
The New York Times:
Companies Fined $325,000 For Selling Pesticide To Fight Coronavirus, E.P.A. Says
Two New Jersey-based companies have agreed to pay a total of $325,000 in fines for selling a pesticide that federal officials say was falsely marketed as a disinfectant spray that could help eliminate the coronavirus, according to the U.S. Environmental Protection Agency. The product, Zoono Microbe Shield, from Zoono USA and Zoono Holdings, was sold online through Amazon and other websites and to community centers and was even purchased by United Airlines during the height of the pandemic to disinfect cabins, the E.P.A. said Wednesday in a statement announcing the settlement. (Oxenden, 9/22)